You are here

Medicare

Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report

Fierce Pharma

Tue, 02/28/23 - 10:39 pm

Boehringer Ingelheim

Medicare maintains limits on Eisai’s new Alzheimer’s drug

BioPharma Dive

Thu, 02/23/23 - 04:27 pm

Alzheimer's disease

CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies

American Journal of Managed Care

Wed, 02/15/23 - 10:42 am

accelerated approval

Medicare announces plan to recoup billions from drug companies

NPR

Thu, 02/9/23 - 06:34 pm

Inflation Reduction Act

U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication

Reuters

Tue, 01/10/23 - 10:59 am

CMS needs to strengthen its internal controls to ensure Part B drug payment accuracy, OIG finds

Endpoints

Tue, 01/3/23 - 10:22 pm

Medicare Part B

Pfizer's Supreme Court challenge of US kickback law is 'far-fetched,' HHS says

Fierce Pharma

Thu, 12/15/22 - 11:21 pm

A Supreme Court chill across biosimilar 'skinny' labels could halt billions in Medicare savings

Endpoints

Tue, 11/29/22 - 08:26 pm

President Biden offers another push on drug price savings via executive order

Endpoints

Sun, 10/16/22 - 05:20 pm

Decades-old law keeping older adults from trying new weight loss therapies - and companies are paying millions to try to get it changed

Marketwatch

Wed, 10/5/22 - 10:46 am

US govt addressing Medicare payments for biosimilars

Pharma Letter

Tue, 10/4/22 - 10:35 am

Medicare Part B

Inflation Reduction Act

Medicare Part B premiums to drop 3% next year, partly due to limited Aduhelm coverage

Medical Marketing and Media

Thu, 09/29/22 - 10:23 am

Medicare Part B

Medicare is using one of its biggest hammers to try to fix the dialysis system: how providers are paid

Stat

Mon, 09/19/22 - 09:06 am

chronic kidney disease

The Inflation Reduction Act’s Potential Impact on Research, Launch Strategy

BioSpace

Wed, 09/7/22 - 10:27 am

Inflation Reduction Act

What “Negotiating” With Medicare Means For Drug Makers: A Mixture Of Price Controls And Actual Negotiations

Forbes

Thu, 09/1/22 - 10:40 am

Inflation Reduction Act

In a massive victory for Democrats, Medicare is poised to negotiate drug prices

Stat

Sun, 08/7/22 - 11:31 pm

Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts

Fierce Pharma

Mon, 08/1/22 - 10:53 am

Pfizer loses court battle to keep its Vyndaqel copay assistance for Medicare patients—again

Fierce Pharma

Tue, 07/26/22 - 05:23 pm

copay asssistance programs

Biogen, citing insurance challenges, shutters one of its Aduhelm studies

BioPharma Dive

Wed, 06/22/22 - 06:54 pm

real world data

Alzheimer's disease

Medicare premiums to remain unchanged after Aduhelm price cut spurs review

BioPharma Dive

Tue, 05/31/22 - 11:56 pm

Medicare Part B

Alzheimer's disease

Pages